MGN slightly increased the percentage of apoptotic cells in TE671 (10.71%), NCI-H1299 (10.98%), and MDA-MB-468 (13.26%) cancer cells after MGN treatment (10 mg/mL) (Table 4). This evidence concerns the gene HELT and cancer.